Charity Registration No. 287863 Company Reglstratlon No. 01751398 (England and Walesl ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) EXECUTIVE COMMITTEE'S REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2024
ST. MARY'S CORONARY FLOW TRUST {COMPANY LIMITED BY GUARANTEE) LEGAL AND ADMINISTRATIVE INFORMATION Mèmbèrs Of The Executlve Commlttee Dr R Foale Prol P S Sever Prol R Khamrs Dr R Al-Lamee Prol Z Whinnett MrLR Bailey (Appointed 18 September 20241 Secretary Ms C Kllgallon Charlty number 287863 Company number 01751398 Reglstered oHIc• 78 Harfey Street (Attn Dr R Foalel London W1G7HJ Indèpèndent oxamlner Evelyn PartnersAdvisory SeNices IThames Valley) LLP 22 Wycombe End Beaconslield HP9 1N8
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) CONTENTS Page Execulfve Cornmittee 8 report Independent examlner's report statement of fi'nancial activities Balance sheet Notes lo the flnanclal stalenntS 8~12
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) EXECUTIVE COMMIThEE'S REPORT (INCLUDING DIRECTORS, REPORT) FOR THE YEAR ENDED 28 FEBRUARY 2024 The Members of the Executwe Gommittee present their reFX)rt and financkl statements lor the year ended 28 Febwary 2024. The accounts have been prepared in accordance wrth the accounting FK)licies sel out in note lo the accounts and comFAy wllh the TrLJsI's con511tLJtlon, the Charllles Act 20118nd °Accountlng and Reportlng by Charitles." Statetnent of Recomwended Practice sppllcable to charities prepadng their accounts in accordance with the Fln3ncial RetK)rtlng Standard appll¢able In the UK and Republlc ol Ireland IFRS 102lleffeotlve 1 January 20151. Oblectlve5 and actlvltles 1. The objectives and activities ol our St Mary's Hospital Coronary Flow Trust ICFTI for the year ending 28 February 2024 remain unchanged and are focused on the promotion of research into arterial vessel disease and trardiovascLJlar health. We have continued support for Imperial College Electrophysiolooy, a world class subspecialty of cardiovascular disease. Our overall iemS1 lor research funding stream is lo provide support for doctois in Ihelr egily research careers 10 88S181 thelr applications to the larger established grar)t organisations. e.g., British Heart Foundation. We, the CFT have. with the Foundation lor Circulatory Health IFFCHI, based our activity from offices at both Sl Mary's Hospital clinical site and the Hammersmith Hospital campus. This spatr prowdes essenllql research Offi support, 2. We contlnue lo be active In background support ollunlor colleagues at Imperial College Trust lo support research goals of the Trust. Exceptional funding has been given for travel grants lo specified individuals may further the aims ol the Trust, lo the Annual Conference where dinical ar research outcomes at Imperial college are presented, to IT Support lor executives lo help further their work, and to projeds and relurblshment lor office bullding and decorallve works to house those colleagues wrth a direct interest In the Trust. 3. In Fobruary 2021. the early work of the Coronary Fbw Trust wblh rosppcl to physlologlcal mgasurements of coronary flow (J Davies, S Sen, el all were recognised by workl acknowledged QUK1elines wblBhed by the Joint Cardiology Guldeline Committee ol the American College ol CardiologylAmerican Heart Association, projects based on there works are In progress. There has been further development of eleclrophysiological research and support through the fundiaising activitles fiorn Di Zach Whinnett recently appointed to the executive comrnlttee to provide EP Sllsight loi giant applications Involving this speciality. The euirent dliectlon of research, which Is funded partly by th8 CFT, is In examinlng the autonorni¢ n8rYous system conliol ol th8 aliiLJm of the he8rt wlh a vlew lo developlng new technologies lo modify this important pathway in patients with lachy or brady arrhythmia. 4. The proposal lo slieamllne the funding into CFT named fellwshiF6 has advanced. These lellowsh'ps will have the advantage of Idenlifylng the IndlvidLJals who have SUPFX)rted the Coronaiy Flow Trust and be named as CFT fellowshlp5. The objectives and actlvlties have continued lo prlnclpally promote research into arterial disease of the heart. Vve have been funding Inlerlrll support for young doctors movlng from an early trailllng arena lo research activities and enable them to lind space lor developlng research based al Imperial College until successful grant applications from established organlsalions have been achieved. We have Continued our association with the foundation lor ¢irculalory health IFFCHI. Publications have and revolve around the development of IFR techniques, that is to S3y pressure wire measureThents of a significant coronary stenosl8 in coronaiy artery disease. These techniques have been developed and have achleved worldwde recognitlon and status and Ihelr beginnings are due to the support from the St Mary's Coronary Flow Trust. The members ol the Executive Commlttee have paid due regard to guvjance issued by the Charity Comffllsslon in decidlng the advisability of funditu lor such pioje¢ts. Applications have also been accepted and more are being considered lor developments into the electrical field ol the heart and publications have resulted from thk5 Important developing fle, based al Hamrnersrntth Hospital. under the directions ol Prof Zach Whlnnett, Professor in Electrophysiology. 5. The commlllee meets regularly to conslder proposals pul IoDNard by members wilhln Imperial College. Whll31 pplicalions 3re considered from all seclois, wlthln the lim of the constilulion, pilority Is en to coronary flow related pr8¢1i¢e. as indeed suggested in our name, and associated electrical conditions. The Trustee8 maintain the policy whlch Is communlcaled to the benellclaiies, ol making one off grants wlth no guarantee ol long term lundlng. bul the possibility ol lulure funding conlingenl on successful research outcome. Thus lo emphasise, the principal underlying this funding is lo provide a bridge until the new researchers Can obtain grant giving agency funding. 6. During the period under review, the Trust did not have any etnployees.
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) EXECUTIVE COMMITTEE'S REPORT (INCLUDING DIRECTORS. REPORT (CONTINUED) FOR THE YEAR ENDED 28 FEBRUARY2024 The Members of the Executive Committee have paid due regard lo guidance issued by the Charity Commission In deeiding what activlbes the Trust should undertake. Achievements and performance The Coronary Flow Trust will continue to support individuals working within this domain and lo build on the succe88es ol the last several years. The Trustees will atternpt to keep abreast of compliance issues in relation lo governan ol this charity, There arg many exatlng new developments including some early SUC$$ in publishing work on pressure and flow rneasuremenl in native and experimental coronary artery models. This represents a tnajor advance for the Trusvs aims and the TruBI will continue to develop this research and atteffl lo obtain higher funding levels for Ihiq. In addillon lo the earfy IL)ndlw ol Or Jusffin Davis, work to which there hag been earlier eommenl, where there were world breaklng technologies In the idenlific3tlon of 8rteiial narrDwng Significance, there has been an extension ol this success with groundbreaking publications In the New England Journal of Medicine IDr Rasha Al-Lameel on triak where angloplasly and medlcal therapy are compared. This development ol an analysis lo examine the basic principle ol whether coronary intervention will work or not, notwilhslanding the technologies Used to defi.ne this suc¢ess, being a fundamental part of ¢lini¢al practi¢e. The CFT 18 proud to be part of thi8 InS1iallve and wlll 1Skely benelrt Irtsm the publlcbty of the CFT'S report In these directlons. Promslon should be made lo ¢onlinue ORBITA support. Flnanclal rèvl$w The results lor the year are sel out on page 6. The Members of the Executlve Commrttee have adopted a reserves policy that will. for a tryear perfod, protect the personnel involved in the developrnenl ol the Coronary Inlerventlonal database. The Executlve Committee recognize that hawng satisfied numerous gi8rn1 applications over the last twelve month5, that we would look very carefully al additional applications ir) an gttewpl lo keep the re8erves at £300,000. Currently the reserves of the Trust are £323,754 comsyared to reserves held as 012023 of £334.807 and 2022 01 £358,158 . The Executive Committee ha5 assessed the major risks to which the Trust is exposed, and are sallsfied that systems are in place lo rniligale exposui8. Plans for future periods The Coron8ry Flow Trust Wll contlnue to supwrt individuals worklng wbthin Ils domain and lo build on the suc¢esses ol the last several years. The Tru51ee5 will consider ajditional Trustees should this be required on the Executive Committee, and the Trust will attempt to keep abre&sl ol complbgnce Issues In relation to governance ol this charlly.
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) EXECUTIVE COMMIThEE'S REPORT {INCLUDING DIRECTORS. REPORTI ICONTINUEDI FOR THE YEAR ENDED 28 FEBRUARY 2024 structure, governance and management The Trust is a ¢ompany limited by guarantee and has no share capital. The company was incorporated on e September 1983. Each member has undertaken lo contilbule to the as8els of the company In the event of the sams being woulld up while helshe is a membei, or within a year of ceaslng to be a mernber, for payment of debts and liabilitles of the eompany contracted before tEasSng to be 8 member, and ol the G08ts, charges and expense8 01 winding up, and lor the adjuslmenls of the rights of the contributors amongst Ihernselves, such amount as may be required not exceeding £1. The company Is a reglstered charlty (Number 2878631. The directors of the company are also ch8rf1y trustees and under the comp8ny's Articles of Association are known as members ol the Executive Committee. Members ol the Executive Committee musl be members ol the company. The Members ol the Executive Comrnmtee, who are also the directors lor the purpose of company law, and who served during the year and up lo the date ol slgnature of the financlal slalements were.. Dr R Foale Prol P S Sever Prof R Khamis Dr Sayan Sen Dr R Al-Lamee Prol Z Whbnnett Mr L R Balley (ReSned 7 October 20241 (Appolnted 18 September 20241 The trustees rneet on a monthly b3sls Inlomally arKI on an annual basis for the AGM. The day to day runnlng of the harrty 1$ undertaken by Chantell Kilgallon, company secretary and Mr Sob Balley Is the non-medlcal Iiuslee and has been appointed as Director ol CFT. The ExecUte Comrnlltee hag assessed the malor rlsks to whlch the TnBt Is exposed, and are satlsfled that systems are in place lo mitigate exposure lo the rnajor risks.
ST. MARY'S CORONARY FLOW TRUST {COMPANY LIMITED BY GUARANTEE) EXECUTIVE COMMITTEE'S REPORT (INCLUDING DIRECTORS, REPORT) (CONTINUED) FOR THE YEAR ENDED 28 FEBRUAR Y2024 statemènt of Exacullve Committee's ve$ponslbllltle8 Tha Members ol the Ex8cullva Committee, who are 8lso th9 dlreclors of Sl. Ma$ Coronary Flow Trust for lh6 purpose of company law, are rospon$lble for prepartng the Execullve Committee's Report and the aocounls In aeLordance wllh applloable law and Unitgd Klngdom Accounting Standards (United Klngdom Generalty Acc8pl6d A¢oounling Pr8Glicel. Company law requlre8 the Members ol tha Executive Commillee lo prepgre aocounts for eaoh finaneJ31 year whlch glve a Irua and falr vlew of the slate of affalrs of the Tiust and of the Incomlng resouyces and ap#lcallon ol resources, in¢ludlng th8 Income and expenditure. of the charitable comp8ny for that yèar. In pr8P8rfng Ihase accounts. th9 Members of the Execullve Committee are requlred lo.. select suSlabl8 aCUntIng pollcles and then apply them conslslently., observ8 Ihe methods and prfnolples In Ihe Charlues SORP., make judgements 8nd estimates Ihal are reasonable and prudent., state wh8lher applloable UK Accounllng Slandards have been fdlowed, Subleol lo any ma181ial dep8riure8 dlsclosod and 8xplaSned in thè accounts,. and prepare the ao¢aunig on tho golna ¢Onrn basls unléss It Is InapproprSal8 lo presume that th8 Trust wlll ¢onllnue In oparallon. The Members of the Executivo Cdmmlllee are responslble for kEepiw adequate aeoounllng records Ihat dlsclose with reasonable auracY 91 any lime lh6 finandal poslllon of the Trust and enable them to ensur8 that the aceounls comply wilh th8 Companles Act 2006. Th8y are asso responslblè for saf8guardlng the assets of tho Trusl and hence for taking reasonablo steps foT Ihe prevention and delecllon ol fraud And other 5rregularilles. The Execullve Commltlea's report was approved by the Board of Memb6rs Of Th6 Execullve Cornmlllee. Dr R Foale 27 November 2024
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) INDEPENDENT EXAMINER'S REPORT TO THE MEMBERS OF THE EXECUTIVE COMMirrEE OF ST. MARY'S CORONARY FLOW TRUST I report to the Members ol the Execullve Comrnlllee on my examlnalion of the financial slalements of St. Mary's Coronary Flow Trust Ith8 Tiusll foi the year ended 28 February 2024. Re5ponslbllltle8 and basls of report As the Members ol the Executive Committee of the Trust land also rts directors for the purposes of eompany lawl you are responslble for the preparation of the flnancl21 statements In accordan¢e with the requirements of the Companies Act 2006 (the 20Ce Act). Having sallsfied mysell that the flnancial slaternents ol the Trust are not required lo be a11 under Part 16 01 the 2006 Act and are eligible lor independent examination, I report in respect of my exarningtion of the Tiusvs flnancial slalements carried out under section 145 01 the Charities Act 2011 Ithe 2011 Act). In carrylng out my examination I have followed all the applicable Directions given by the Charlly Comml8sion under section 145 15llbl ol the 2011 Act. Independent exarniner's statement I have cornpleted my examination. I confirm that no mallers have come lo my attention in connection with the examination giving me cause to believe that in any materlal respect.. accounting records were llol kept in respe¢t ol the Tiusl as required by section 386 of the 2006 Act,. or the financlal statements do not accord wilh those recoids., or the financial statements do not comply Vwith the accounllru iequliemen18 01 section 396 01 the 2006 A(* other than any requirement that the accounts give a twe and f3Ir view which is not a matter considered as part ol 8n independent examination., or the finzlldal stalemer)ts have not been prep8red In accordance with the methods and principles of the S131emenl ol Recommended Piacli¢e foi aocounling and reportlng by charities applicable to chairties preparing their accounts in accordance with the Finan¢ial Reporting Siandard applicable in the UK and Republic ol Ireland IFRS 1021. I have no concerns 8nd have come across no other matters Sn connection with the examinah'on lo th1¢h attention should be drawn In Ihls rèport In ordèr lo ènabl8 a woper underslandlng ol the Ilnanclal statements lo be reached. Yuen Man Ann Evelyn Partner er CA FCPAIHKI vi80ry Serviw (Thames Valley) LLP 22 Wycombe End Beaconslield Bu¢kinghamshire HP9 1NB Dated.. 27 November 2024
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 28 FEBRUAR Y 2024 Unrè5trlcted fund5 2024 Unrestrlcted fund5 2023 Notes Income fiom.. Donations and legacies 64,098 45,345 Total Income 84,098 4S,345 Expehditure on: Chaiilable activities 75,151 68,696 Total èxpèndlture 75,151 68,696 Net expenditure and movement in funds 111,0531 123,3511 ReGonclllatlon ol lunds.. Fund balances al 1 March 2023 334.807 358.158 Fund balances at 28 FebruaTy 2024 323,754 334,807 The slalernenl ol financial activrties includes all gains and th5e5 recognised In the year, Ml in(x)Tlle and experKlilure derive from contlnuing activlties.
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) BALANCE SHEET AS Af 28 FEBRUARY 2024 2024 2023 Notes Current assets Cash al bank and In hand 327,234 338,047 Credllors.. omounts falllng duè wlthin one ya8r 10 13,4801 13,240) 334,807 Net currènt assats 323,754 Nel Assets excludlt)g p&n$lon Ilabllity 323,754 334,807 The funds of Ihe Trust Unreslrlcl8d funds 323,754 334.807 323,754 334,807 The company Is enlltled to the exempllon from the eudll requlrernenl conlaln8d In 8ecUon 477 of Ihg Companle8Ad 2006, lorlhe year 8nded 28 February 2024. The dlrectors aoknowledue Ihelr responslbili116s for complylng wilh the requirements of the Companles Act 20r vmlh r8SP801 to accounting record8 and tha prep8r8llon of flnan1 slalemenls. The members have nol requlred the company to oblaln an audit ol ils fTnanclal slalem6n15 for Ihe year In quesllon In accordanc8 wllh sectlon 476. These financial slalements have bgen prepar8d In accordat5¢8 th the provlsions appllcabl8 lo companSes subject lo the small Companles regime. re approved by IhB Mambers of the ExecJJtlve Commltlg9 on 27 November 2024 Th¢ flnanc181 Gta16ments Dr R Foala Company reglslrailon number 01751398 (England and Wales)
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUAR Y 2024 Accounting pollcles Charlty Informallon st. Mary's Coionary Flow Trust Is a private company limited by ouaranlee incorFK)raled Sn England and Wales. The registered office is 78 Harfey Street, (Attn Dr R Foalel, London, W1G 7HJ. 1.1 Accountlng convention The financial statements have been prepared In accordance with the Trusts Igoveming documentl, the Companies Act 2006, FRS 102 'The Financial Reporting Standard appllcable in the UK and Republlc of Ireland. I'FRS 102'18nd the Charities SORP "Accounllng and Reportlng by Charllies.. Slalemenl ol Recommended Practice applieable to charities preparing their 2ccount8 In 8ccordance with the Financial Reportlng Standard applicable in the UK and Republic of Ireland IFRS 1021 leffectlve 1 January 20191. The Trust Is 8 Publio Benefit Entity as dellned by FRS 102. The Trust has taken advantage of the provisions in the SORP lor charllbes not lo prepare a Slalement ol Cash Flows. The linan¢ial statements are prepared in slerllng. which the functlonal currency of the Trust. Monetary amounts in these financbal 51alements are rounded to the nearest £. The financlal slalemenls have been prepared under the hlslorical cost convention. The prlnclpal accounllng policies adopted are set out Lelow. 1.2 Golng cohceTn Al the lime of approving the financial slalemen18. the Members ot the Executive Committee have a reasonable expe¢talion that the Trust has adequate r880uices to continue in operational existence for the foreseeable future. Thus the Mernbers ol the Executive Committee continue to adopt the going Concern basis of acoounling in preparing the flnanclal 8lalementB. 1.3 Charitable fund5 The Trust only holds unreslricled funds, these are lunds which can be used in accordance wlh the charitable companys objectives. al the dls¢relion of the Executive Committee. Reslrleled funds are subject lo spe¢iflc condltions by donors or gianlors as to how they may be used. The purposes aThJ uses ol the reslricled funds are set out in the notes lo the fi'nancial 818lements. Endowment funds are sublecl lo specific condllions by donors that the capital musl be malntalned by the Tiust. 1.4 Income Income Is reGognised when the Trust is legally entitled to it after any Ferforrnance conditions have been mel, the arnounts can be measured reliably. and It Is probable that income will be recelved. Cash donations are recognised on iecelpl. Other donations are recognised once the Trust has been notified ol the donation, unless performance conditlon8 requlre deferral ol the amount. Income tax recover2ble in relation lo donatlons recelved under Girt Aid or deeds ol covenanl18 recognlsed al the Ilme ol the donallor). Voluntary income and donations are accounted for as reoeived by the Trust. All other Income Is accounted for on an acciuals ba81$.
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 28 FEBRUARY 2024 Accounting pollcles {Continuedl 1.5 Expendlture Llabilities are recognised as resources expended as soon as there Ss a legal or constructNe obligation comtnitting the Trust lo the expenditure. All expenditure is accounted for on an accrual basls. Charitable expenditure eomprises those costs incurred by the Trust in furtherance of the objectives of the Trust. Contribution for the funding ol researchers. salaiies ale 8CCOUnted for when paid 01 otherwise when the Trust has comrnitted lo and cornmunlc3ted this to the third party. No ¢onlingent funding Is accrued for. Governance c0818 associated with the preparation the prepar8tlon ol the flnanclal slalements and any other constitutional and slalulory requiiemenls. Where support costs cannot bè direetly attributed lo partIlar headlngs they have been allocated to c08t of ralsing funds 8nd expenditure on charilaNe adlvillos on a basls consistent with u6e of the resources. Irrecoverable VAT Is charged as an expense ag8inst the activity for Mthich expenditure 8rose. 1.6 Cash and ca8h equlval8nts Cash and cash equalents Include cash In hand, depo8lls held at call fj1h banks, othèr short-lerm liqui inveslrnents wth original malurilies ol three month8 or less, and bank overdrafts. 8ank overdrafts are shown wthin borrowings in current li8bilities Derecognltlon of financial liabilities Financlal liabilllies are derecognised when the Trust's Conlraclual obllgallons expire or are dischargod or cancelled. 1,7 Value Added Tax Value added lax Is not recoverable by the Trust, as as such Is Included in the revant costs In the Statemer* ol Finan¢ial A¢livities. Income from donatlons and legacies Unrestrlcted funds 2024 Unrestrlcted funds 2023 Dtsnations and gifts 64.098 45,345
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 28 FEBRUARY 2024 Expendlture on chailtable actlvltles Grant fundings 2024 Grant fundlngs 2023 Direct costs Giant fundlng ol activS1ies (sèe note 41 59,300 53,786 Share of support and governance costs Isee note 51 Support Governance 12,302 3,54S 11,790 3,120 75,151 68,696 Analys18 by fund Unre8lrlded funds 75,151 6B,696 Grants payable Grant fundlngs 2024 Grant fundlngs 2023 Grants to inslilullons.. Other 49,894 40,000 Grants to indlvlduals 9,406 13,786 SuppoTt Costs Support GoveTnance costs costs 2024 Support Govern8llC8 Costs costs 2023 Adminlstralive setvices 12,302 12,302 11,790 11,790 Governan¢e costs 3,549 3,549 3,120 3,120 12,302 3,549 15,851 11.790 3,120 14,910 Analysed between Charllable aclivllie8 12,302 3,549 15,851 11,790 3,120 14,910 Govemanace costs include payment to the Independent examiner of £3,$4912023 £3,120) lor independent examiner's lees. 10-
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 28 FEBRUARY2024 Net movement In funds 2024 2023 The nel movement in funds is slated after charging/1edrtingj'. Fee8 payable for the Independent examin81ion of the charity's financial slalernenls 3.549 3.120 Members Of The Executive Committee None of the Memb8rs ol the Ex8CUtiV8 Committee lor any persons connected with them) ieceived any reUneratIOn 01 benelrts from the Trust durino the year. Employee5 The average monthly number ol employees during the year was.. 2024 Number 2023 Number Total There were no empbyees whose annual remuneratlon wa$ more than £60.000. Taxatlon The Trust Is registered charity, number 287863. 11 Is exempt from taxatlon118bllltles on Its Income. 10 Creditors.. amounts falling due within one year 2024 2023 Acuuals deferred Income 3.480 3,240 11 Unrestricted funds The unreslricled funds ol the ¢harily comprise the ungxpended balances ol donations and grants whlch are not 8ubjed to specific conditions by donors and granlois a8 to how they may be used. These include deslgnaled funds whlch have been sel aslde out of unresliicted lund8 by the Iiuslees for specific purposes. At l March 2023 Incomlng resources Resouices At28 èxpended February 2024 General funds 334.807 64,098 175,1511 323,754
ST. MARY'S CORONARY FLOW TRUST (COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 28 FEBRUAR Y 2024 11 Unrestricted funds Iconlinuedl Previous year: At 1 March 2022 Incomlng resources Resources At28 expended FebrLtary 2023 General funds 358.158 45,345 168,6961 334,807 12 Related party Iransadlons There wore no dlsGlo8able related party Iransactlons durfng the year12023 none). 12-